Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (27)
  • 2025 (85)
  • 2024 (95)
  • 2023 (85)
  • 2022 (161)
  • 2021 (100)
  • 2020 (6)
  • 2019 (8)
  • 2018 (10)

Subject

  • Drug Trafficking (4305)
  • Synthetic drugs (1173)
  • Guns/Weapons (1067)
  • OCDETF/Task Force (827)
  • Fake Pills (705)
  • Arrests/Convictions - Major (684)
  • Seizures (Drugs/Property) (503)
  • Prescription Drugs (386)
  • Overdose (335)
  • Major Law Enforcement Operation (290)
  • Diversion Division (265)
  • Take Back Day (257)
  • Task Forces/Task Force Officers (252)
  • Pharmaceuticals/Pharmacists/Physicians (234)
  • Money Laundering (222)
  • Gangs (206)
  • Outreach/Drug Prevention (194)
  • Fentanyl Awareness (178)
  • One Pill Can Kill (124)
  • HIDTA (105)
  • Press Conferences (70)
  • Fentanyl Free America (62)
  • Counterfeit Pills (55)
  • Extraditions (55)
  • Narcoterrorism (55)
  • Prevention/Education - DEA websites GSAD, JTT etc (55)
  • Public and Media Affairs - also see Congressional Affairs (52)
  • Asset Forfeiture (30)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (29)
  • Red Ribbon (28)
  • Campaigns (18)
  • Terrorism (15)
  • Other (14)
  • Critical Incident (10)
  • Cartel (9)
  • Intergovernmental Affairs (9)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Guilty Plea (563)
  • Congressional Affairs (15)

Drug Name

  • Methamphetamine (227)
  • Fentanyl (172)
  • Cocaine (134)
  • Heroin (79)
  • Marijuana (Cannabis) (24)
  • Oxycodone (12)
  • Synthetic Opioids (11)
  • Opioids (8)
  • Ecstasy/MDMA (4)
  • Ketamine (4)
  • Morphine (4)
  • Steroids (3)
  • Methadone (2)
  • Amphetamines (1)
  • Benzodiazepines (1)
  • Marijuana Concentrates (1)
  • Synthetic Bath Salts or Designer Cathinones (1)
  • Xylazine (1)

Field Division

  • Atlanta (29)
  • Chicago (167)
  • Dallas (12)
  • Detroit (6)
  • El Paso (21)
  • Houston (22)
  • Los Angeles (4)
  • Louisville (4)
  • Miami (85)
  • New England (9)
  • New Jersey (36)
  • New Orleans (1)
  • New York (12)
  • Omaha (6)
  • Phoenix (6)
  • Rocky Mountain (2)
  • San Diego (7)
  • San Francisco (22)
  • Seattle (41)
  • Sede (12)
  • St. Louis (41)
  • Washington, DC (31)
Clear All Results
577 Results - Showing 561 to 570
PRESS RELEASE

South Florida doctor pleads guilty to conspiring to illegally distribute oxycodone

Dr. Rodolfo Gonzalez Garcia, 65, of Weston, Florida pled guilty on August 23, 2019, to conspiring to dispense a controlled substance, Oxycodone, before U.S. District Judge Roy K. Altman (Case No. 19-cr-20055). According to the court record, including the agreed upon factual proffers, from November 2016, through and including September...
PRESS RELEASE

Tampa man on federal supervised release pleads guilty to laundering proceeds of synthetic marijuana conspiracy

Jacksonville, Fl a . - Arafat Aljubeh (54, Tampa) has pleaded guilty to conspiring to launder the proceeds of a conspiracy involving the distribution of a synthetic marijuana referred to as “AB-FUBINACA .” At the time of the offense, Aljubeh was on federal supervised release stemming from a 2014 federal...
PRESS RELEASE

Winter Garden convicted felon pleads guilty

ORLANDO, Fla. – Kenneth Bernard Smith, 54, of Winter Garden, Fla., pleaded guilty today to two counts of possessing ammunition and a firearm as a convicted felon and two counts of distributing cocaine and heroin. He faces a mandatory minimum penalty of 15 years, and up to life, in federal...
PRESS RELEASE

Fentanyl and heroin darknet vendors indicted

SACRAMENTO, Calif. — A Rancho Cordova woman was indicted on April 4, 2019, charged with distribution of fentanyl and oxycodone and other opioids as a result of a coordinated operation by the U.S. Attorney’s Office, the Federal Bureau of Investigation, Homeland Security Investigations, the Drug Enforcement Administration and the U.S...
PRESS RELEASE

DEA announces enhanced tool for registered drug manufacturers and distributors to combat opioid crisis

WASHINGTON – The Drug Enforcement Administration today announced the launch of an enhanced system to help more than 1,500 registered drug manufacturers and distributors nationwide more effectively identify potential illicit drug diversion and combat the opioid epidemic. On Oct. 24, 2018, President Trump signed into law the “Substance Use–Disorder Prevention...
PRESS RELEASE

Manhattan U.S. Attorney announces extradition of OFAC- sanctioned Afghan man for Narco-Terrorism offenses

NEW YORK - Christopher Tersigni, Special Agent in Charge of the United States Drug Enforcement Administration Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced today the extradition of Haji Abdul Satar Abdul Manaf, aka “Haji Abdul Sattar Barakzai,” for...
PRESS RELEASE

Worcester restaurant manager pleads guilty to money laundering conspiracy and attempted witness tampering

BOSTON – A Worcester restaurant manager pleaded guilty yesterday in federal court in Worcester to conspiring with the wife of a convicted drug dealer to use drug proceeds to renovate and operate a Shrewsbury Street restaurant. Joseph Herman, 37, pleaded guilty to conspiracy to commit money laundering, making false statements...
PRESS RELEASE

DEA releases 2018 National Drug Threat Assessment

WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced results of the 2018 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. “This report underscores the scope and magnitude of the ongoing opioid crisis...
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
PRESS RELEASE

DEA investigators seeking answers in small Tennessee town

CELINA, Tenn. -- DEA investigators this week conducted inspections at several pharmacy locations in the Clay County, Tennessee town of Celina, following an inquiry into irregular patterns of pill purchases from drug distribution companies. DEA is now investigating possible criminal activity involving the illicit diversion of controlled prescription pharmaceuticals at...

Paginación

  • Primera página «
  • Anterior
  • Page 50
  • Page 51
  • Page 52
  • Page 53
  • Page 54
  • Page 55
  • Page 56
  • Current page 57
  • Page 58
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster